17 case studies found
Dr Michael Eyres, Lead Scientist at MDC, has been working on applying MDC’s biomarker expertise to a novel approach in drug discovery.
What does hypoxia look like inside a tumour, cell by cell? Our team can map it, single-cell spatial transcriptomics for up to 5,000 targets in standard FFPE tissue.
MDC Helping UK SMEs access tissue samples, a collaboration with Tissue Solutions.
A collaboration with the MS Society
Supporting pHion Therapeutics with an Invest NI Innovation Voucher
A workshop co-hosted by the Psychiatry Consortium and the Psychiatric Genomics Consortium
MDC and Boehringer Ingelheim collaborate to organise a consultative ‘round table’ meeting providing an opportunity for hearing research innovators to access industry-leading insight and expertise on the development of their hearing therapeutic programme.
Accelerating translation of more predictive research models for drug discovery
Insights from a survey of 121 genomics companies headquartered in the UK
Novel Biomarker Strategies to Improve the Success of Drug Discovery
See how we can help support you with your next drug discovery project.
Speak to us
